Keros Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $44.3M | $615.9M | $559.9M |
| FY2025 | $34.9M | $338.0M | $287.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $44.3M | $615.9M | $559.9M |
| FY2025 | $34.9M | $338.0M | $287.4M |